Clinical validation of clinical decision support systems for medication review: A scoping review

The aim of this scoping review is to summarize approaches and outcomes of clinical validation studies of clinical decision support systems (CDSSs) to support (part of) a medication review. A literature search was conducted in Embase and Medline. In total, 30 articles validating a CDSS were ultimatel...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of clinical pharmacology Vol. 88; no. 5; pp. 2035 - 2051
Main Authors Damoiseaux‐Volman, Birgit A., Medlock, Stephanie, Meulen, Delanie M., Boer, Jesse, Romijn, Johannes A., Velde, Nathalie, Abu‐Hanna, Ameen
Format Journal Article
LanguageEnglish
Published England John Wiley and Sons Inc 01.05.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The aim of this scoping review is to summarize approaches and outcomes of clinical validation studies of clinical decision support systems (CDSSs) to support (part of) a medication review. A literature search was conducted in Embase and Medline. In total, 30 articles validating a CDSS were ultimately included. Most of the studies focused on detection of adverse drug events, potentially inappropriate medications and drug‐related problems. We categorized the included articles in three groups: studies subjectively reviewing the clinical relevance of CDSS's output (21/30 studies) resulting in a positive predictive value (PPV) for clinical relevance of 4–80%; studies determining the relationship between alerts and actual events (10/30 studies) resulting in a PPV for actual events of 5–80%; and studies comparing output of CDSSs to chart/medication reviews in the whole study population (10/30 studies) resulting in a sensitivity of 28–85% and specificity of 42–75%. We found heterogeneity in the methods used and in the outcome measures. The validation studies did not report the use of a published CDSS validation strategy. To improve the effectiveness and uptake of CDSSs supporting a medication review, future research would benefit from a more systematic and comprehensive validation strategy.
Bibliography:Funding information
Innovation funds of Amsterdam UMC, location AMC
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Funding information Innovation funds of Amsterdam UMC, location AMC
ISSN:0306-5251
1365-2125
DOI:10.1111/bcp.15160